Form D · Other
Agragene, Inc.
San Diego, CA · CIK 0001821147
Offering snapshot reported Feb 22, 2021 · SEC filing
- Reported sold
- $145K Offering amount: $145K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 5, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 22, 2021 | Initial | $145,000 | No comparison | 1 | SEC filing |
| Aug 24, 2020 | Initial | $2,072,839 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-390068
Source: Form D, filed Feb 22, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gordon Alton | Director, Executive |
| Carl Casale | Director |
| Tracy Ellis | Executive |
| Robert Schmidt | Director |
| Clyde Shores | Director, Executive |
| David Webb | Director |
Issuer details
Industry: Other (See others in industry)
Address:
9885 Mesa Rim Road, Suite 103
San Diego, CA, 92121
San Diego, CA, 92121